Your Body Already Makes This Drug
What the GLP-1 conversation is missing , and why acupuncture belongs in it.
Semaglutide is everywhere right now. My patients are asking about it, my colleagues are debating it, and the research literature is quite literally ablaze with new findings. Some of those findings are genuinely remarkable, but what’s interesting to me is what isn't making headlines: acupuncture may be working on the exact same pathway, from the inside out.
TL;DR
This isn't a takedown of GLP-1 receptor agonists. I see firsthand that these medications are doing real things for real people: reducing systemic inflammation, improving metabolic markers, and in some cases changing outcomes that acupuncture alone cannot. What this is, instead, is a conversation about where acupuncture fits: alongside, underneath, and in support of whatever someone is doing for their health… in this case, including a GLP-1 medication.
First: What Is a GLP-1, Actually?
GLP-1 stands for glucagon-like peptide-1. It's a hormone your gut (primarily in the small intestine) produces naturally in response to eating. When it's working well, GLP-1 signals the brain to reduce appetite, stimulates insulin release, slows gastric emptying, and helps regulate blood sugar. It's a sophisticated, multi-system satiety signal.
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and liraglutide work by mimicking and amplifying this signal pharmacologically. They don't teach the body to regulate; they just step in and do it artificially (this is the way of the pharmaceutical).
This is why the weight loss can be dramatic, and also why, in studies, people who stop the medication regain a significant portion of the weight within a year. The drug was doing the work. The body's own system wasn't rebuilt. (This is where you’re gonna remember that this is written by an acupuncturist.)
FROM THE RESEARCH
A 2024 umbrella review in Nature Communications covering 123 meta-analyses found that GLP-1 receptor agonists show trends toward improvement across endocrine, metabolic, cardiovascular, renal, and cognitive outcomes, with potential reduction in all-cause mortality in certain populations. The inflammation reduction alone is significant: these medications appear to modulate systemic inflammatory load in ways that go well beyond weight loss.
That breadth of that is worth sitting with: these aren't just weight loss drugs, and as someone whose work centers reducing inflammatory input, pathways, and responses, I find this to be incredible.
What’s not incredible but also makes sense for a pharmaceutical: separately, a 2025 systematic review and meta-analysis with 3,771 participants found that people with obesity who stopped a GLP-1 medication regained an average of 5.63 kg, with the longer follow-up duration, the more the weight came back.
That points to the value of building parallel support: it’s not that you avoid the medication, but rather you couch your medical decisions with holistic support.
Where Acupuncture Enters the Picture
How does acupuncture suppresses appetite in obese subjects? A 2025 study found that acupuncture's effects are mediated through what they're now calling the vagal–GLP-1–ARC circuit: a pathway running from vagal afferent nerve fibers up through the nucleus tractus solitarius (NTS) in the brainstem, into the hypothalamic arcuate nucleus (ARC). The NTS is the primary middleman between the body and the brainstem when it comes to visceral, aka internal, sensory information, while the ARC is, simply, the control center for hunger.
Nerd alert!
What does that actually mean?? It means that acupuncture talks to the brain's primary appetite-regulation center.
In obese rats, GLP-1 expression in the NTS was significantly reduced. Electroacupuncture and transcutaneous auricular vagal nerve stimulation both restored it.
This means that acupuncture mimics GLP-1 from inside the system. It stimulates the body's own GLP-1 neurons to fire by working with the vagus nerve to restore a signal the body had lost the ability to send clearly.
And because it’s an inside job, it’s teaching the body to do something rather than overriding the system and taking over.
Semaglutide is an external agonist, which means it occupies the receptor and drives the signal. Acupuncture, through vagal stimulation, appears to be rehabilitating the neuron itself. These are not the same thing, even when the downstream effects overlap, but it does pique my interest when the two are used in conjunction with one another.
If semaglutide is taking over for the signal at the same time that there’s neuronal rehabilitation, then what happens when the dosage is lowered and then spread out? Can the combination of a GLP-1 agonist and acupuncture, done well, retrain your brain?
The Vagus Nerve Connection
This finding maps cleanly onto what we already understand about acupuncture's relationship to the vagus nerve. Points on the ear, belly, and along the stomach and spleen channels all have documented effects on vagal tone (the same cranial nerve that is, it turns out, central to endogenous GLP-1 signaling). Acupuncturists know that the gut-brain axis isn't a metaphor but rather an anatomical highway through which satiety, digestion, inflammation, and mood all travel.
So much of what acupuncture does is de-congest that highway: we take the traffic caused by chronic stress, dysbiosis, metabolic dysfunction, years of ignored hunger signals and utilize acupuncture to remind the body of its own ability to regulate appetite from the inside. Because otherwise, modern life seems to cause GLP-1 production to drop. The arcuate nucleus stops receiving the signal. Hunger becomes dysregulated, disconnected from actual need.
Acupuncture has always worked at this intersection and run incredible traffic control.
We just now have the molecular language to say why.
So here's the actual clinical picture, as I see it:
If you're on a GLP-1 medication: acupuncture can support what the drug is doing. Better vagal tone means better gut motility (relevant for the GI side effects many people experience). Acupuncture day of medication injection cuts symptoms (based on my small sample size). Nervous system regulation means lower baseline stress load, which matters for inflammation and metabolic function. The wiring underneath is worth tending even when the medication is doing excellent work on top.
If you're considering a GLP-1 medication: acupuncture is a reasonable first conversation, or a parallel one. Especially if what's driving your metabolic dysregulation has a significant nervous system or stress component, addressing that directly may move the needle more than you expect. And if you ultimately move toward medication, you'll be starting from a more regulated baseline.
If you're not on one and don't want to be: acupuncture offers a pathway through the same circuit, just via different means. The endogenous GLP-1 stimulation, vagal activation, and system-level regulation is all still there, it just doesn't require an external agent. The research is increasingly clear on the mechanism. The effect sizes won't match pharmaceutical intervention, but the approach is sustainable, cumulative, and side-effect-free.
None of these paths are in conflict. They're just different leverage points on the same problem.
GLP-1 medications are doing genuinely useful things, like reducing inflammation in ways that go beyond weight loss. This is so clinically relevant and interesting to me, since I see how acupuncture works in similarly adjacent and yet different way: the vagus nerve, the gut-brain connection, the nervous system's ability to regulate stress, sleep, digestion, and appetite from the inside.
These aren't competing approaches and I love to see them used together.
If you're on a GLP-1, acupuncture can support your body through the transition and address the layers the medication doesn't reach. If you're considering one, it's worth knowing what acupuncture can shift first, or how it can be used alongside the medication. And if medication isn't part of your picture, acupuncture offers a pathway through the same underlying circuitry. There's a seat here for wherever you are.
What the Research Shows on Acupuncture Alone
Beyond the mechanism studies, the clinical outcomes literature is building. A 2024 systematic review and network meta-analysis evaluated 14 randomized controlled trials across acupuncture modalities for overweight individuals and obesity. Electroacupuncture added to usual care produced meaningful reductions in body weight compared to usual care alone. Auricular acupuncture also showed effects on waist circumference and BMI.
The effect sizes aren't the same as pharmaceutical intervention, because we don’t live in a world where it’s possible for anything but a pharmaceutical to have these effects (time and money constraints make sure of that). And that same world that we live in glorifies more is more, so I get the flocking to the GLP1s.
But with acupuncture, what’s so neat is that the mechanism is endogenous, the side effect profile is incomparably cleaner, and importantly, the body is doing the learning. That's no small thing when the goal is sustainable, long-term, metabolic health.
What We’re Working With
From a systems perspective, acupuncture in metabolic contexts is addressing several layers simultaneously: the hypothalamic-pituitary-adrenal axis (chronic stress as driver of metabolic dysregulation), the enteric nervous system and gut microbiome signaling, vagal tone and parasympathetic recovery, inflammatory load, sleep architecture, and, relevant to GLP-1 specifically, the neuroendocrine signaling between gut and brain that governs hunger and satiety.
These aren't separate targets! They're all one system! And they all run through the same nervous system that acupuncture has been regulating for over two thousand years.
The Question Worth Asking
GLP-1 medications are revealing something important about metabolic health: the fact that the hunger circuit, the satiety signal, the body's ability to read its own internal states are not fixed. And not only can they be disrupted, but they can be supported.
Cardiovascular benefit, cognitive outcomes, inflammation reduction, and liver health are all documented benefits of GLP-1 agonists. It's a genuinely exciting moment in metabolic medicine. And it's also a moment that creates a clear opening for what acupuncture has always offered: nervous system regulation, vagal support, and the kind of systemic recalibration that no pill, however effective, can fully replicate.
